Jacobs Levy Equity Management, Inc Sqz Biotechnologies CO Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $187,276 - $338,045	-67,609 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.01 - $10.42 $271,112 - $704,485	67,609 New	67,609 $325,000
Q3 2021 Nov 15, 2021	SELL	$11.46 - $15.77 $792,905 - $1.09 Million	-69,189 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$11.32 - $14.45 $511,199 - $652,547	45,159 Added 187.93%	69,189 $1 Million
Q1 2021 May 17, 2021	BUY	$12.07 - $29.9 $290,042 - $718,497	24,030 New	24,030 $329,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.